An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

Highlights

ProCAncer-I in the IEEE-MeMeA Conference in Taormina

ProCAncer-I in the IEEE-MeMeA Conference in Taormina

Jun 17, 2022

We are looking forward to participating it the upcoming IEEE-MeMeA Conference in Taormina! The 17th edition of IEEE International Symposium on Medical Measurements and Applications will take place in Giardini Naxos, Taormina in the metropolitan area of Messina,...

1st ProCAncer-I Project Dissemination Event in Vienna

1st ProCAncer-I Project Dissemination Event in Vienna

May 31, 2022

We are really happy to announce that we will be present at the ECR Congress in Vienna on 13 - 17 of July 2022. During the congress, a special Session will take place  on the 15th of July, presenting and discussing on the ProCAncer-I project with the title: Building...

Use Cases mapped along the prostate cancer management continuum

Use Cases mapped along the prostate cancer management continuum

Apr 6, 2022

Nowadays, prostate cancer is highly curable if detected in its early stages. Indeed, when organ-confined at diagnosis, the five-year survival rate of prostate cancer is close to 100%. Unfortunately, current prostate cancer diagnostic pipeline has several limitations. Prostate specific antigen (PSA) has a low sensitivity and specificity.

ProCAncer-I Follow

Avatar
Avatar ProCAncer-I @procancer_i ·
22 Jun

👏New paper published! 👏
How the ability of radiomic features to discriminate different image textures varies with the volume of the analyzed region.
➡️ https://www.mdpi.com/2076-3417/12/11/5465
.
.
.
#cancer #reasearch #health_data #data_imaging #artificialintelligence #ai #health #data

Reply on Twitter 1539514988041232385 Retweet on Twitter 1539514988041232385 2 Like on Twitter 1539514988041232385 6 Twitter 1539514988041232385
Avatar ProCAncer-I @procancer_i ·
17 Jun

We are looking forward to participating it the upcoming IEEE-MeMeA Conference in Taormina with a👉 special session & a👉study!
Read more 👉https://www.procancer-i.eu/news/procancer-i-in-the-ieee-memea-conference-in-taormina/

#H2020 #EU_HEALTH #artificialintelligence #ai #health #data #IEEE #memea2022

Reply on Twitter 1537678167711920131 Retweet on Twitter 1537678167711920131 2 Like on Twitter 1537678167711920131 5 Twitter 1537678167711920131
Avatar ProCAncer-I @procancer_i ·
14 Jun

Professor Tsiknakis took part in a recent feature in the @EUCouncil site on data availability in the 🇪🇺EU🇪🇺 and the use of #data for research purposes and innovation. Read more ⬇️
https://bit.ly/3NLvpD0
#ai #data #H2020 #EU_HEALTH

Reply on Twitter 1536605002986360835 Retweet on Twitter 1536605002986360835 4 Like on Twitter 1536605002986360835 8 Twitter 1536605002986360835
Retweet on Twitter ProCAncer-I Retweeted
Avatar Quibim @quibimbiomarker ·
9 Jun

Nowadays, #prostatecancer diagnosis is not ideal. It usually requires a painful procedure and is not always exempted from certain side effects. So, is it possible to detect this pathology in a non-invasive way?
https://bit.ly/3mtX8ft
#AI

Reply on Twitter 1534853166847737856 Retweet on Twitter 1534853166847737856 9 Like on Twitter 1534853166847737856 11 Twitter 1534853166847737856
Avatar ProCAncer-I @procancer_i ·
7 Jun

👏Congrats!👏
New conference presentation "On the Effectiveness of 3D Vision Transformers for the Prediction of Prostate Cancer Aggressiveness" at the workshop "Medical Transformers" afferent to the #ICIAP2021
#H2020 #EU_HEALTH #cancer #reasearch #health_data #data_imaging #ai

3

Reply on Twitter 1534101114517393408 Retweet on Twitter 1534101114517393408 3 Like on Twitter 1534101114517393408 6 Twitter 1534101114517393408
Load More...

Stay in touch!